Emerging therapeutic targets in ovarian cancer / [electronic resource]
Stan Kaye [and others], editors.
- New York : Springer Science+Business Media, LLC, ©2011.
- 1 online resource (xiii, 291 pages) : illustrations
Includes bibliographical references and index.
Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.
This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
9781441972163 1441972161 9781441972156 1441972153
978-1-4419-7215-6 Springer http://www.springerlink.com
Ovaries--Cancer--Treatment.
Ovarian Neoplasms--therapy.
Antineoplastic Agents--therapeutic use.
Drug Design.
Drug Therapy--trends.
Medicine.
HEALTH & FITNESS--Diseases--Cancer.
MEDICAL--Oncology.
Ovaries--Cancer--Treatment.
Electronic books.
RC280.O8 / E44 2011
616.99/465
2011 B-194 WP 322
Includes bibliographical references and index.
Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.
This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
9781441972163 1441972161 9781441972156 1441972153
978-1-4419-7215-6 Springer http://www.springerlink.com
Ovaries--Cancer--Treatment.
Ovarian Neoplasms--therapy.
Antineoplastic Agents--therapeutic use.
Drug Design.
Drug Therapy--trends.
Medicine.
HEALTH & FITNESS--Diseases--Cancer.
MEDICAL--Oncology.
Ovaries--Cancer--Treatment.
Electronic books.
RC280.O8 / E44 2011
616.99/465
2011 B-194 WP 322